D'Cruz, A-M
Mosconi, M W
Ragozzino, M E
Cook, E H
Sweeney, J A
Article History
Received: 4 October 2015
Revised: 15 June 2016
Accepted: 19 July 2016
First Online: 11 October 2016
Competing interests
: JAS has consulted to Lilly, Takeda and Roche. EHC received support from Seaside Therapeutics. The remaining authors declare no conflict of interest.